Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial. (linkinghub.elsevier.com)

Authors: Thorn N … Heath PT Journal: Lancet Infectious Diseases Published: 2026-05-06 DOI: https://doi.org/10.1016/S1473-3099(26)00119-2